Quantitative analysis C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35)

Complement-dependent clearance of immune complexes in humans is dependent on the activation and binding of the early components of the classical complement cascade. This prevents immune complex precipitation and promotes binding of the complexes by the C4b/C3b complement receptor CR1 (CD35) found on erythrocytes, The fourth component of human complement is encoded by two closely Linked genes within the MMC. These genes give rise to the isotypic forms C4A and C4B, and recent studies suggest that CRI binds activated C4A (C4Ab) to a greater extent than activated C4B (C4Bb). To study this difference in a more quantitative way the binding reactions between CR1 and C4Ab- and C4Bb-coated immune complexes and between CRI and soluble dimers of C4Ab (C4Ab(2)) and C4Bb (C4Bb(2)) were analysed using the native receptor on human erythrocytes. The binding reaction between immune complexes with equivalent amounts of covalently bound C4Ab or C4Bb and erythrocyte CR1 showed a two-fold higher binding of complexes coated with C4A. Furthermore, erythrocyte CR1 bound C4Ab(2) with an apparent four-fold higher affinity (K-d approximate to 1.4x10(-7)M) than C4Bb(2) (K-d approximate to 4.8x10(-7)M), indicating a preferential binding of CR1 for C4A.